Chris has 25+ years of life science experience with executive roles in the pharmaceutical, Biotech, Medtech and Health-tech industries. Chris has led organisations and functions at global, regional and country level and has a wealth of therapeutic experience including working extensively in rare and ultra rare diseases. Chris is adept at navigating complex HTA requirements for rare diseases and is particularly interested in understanding how to shape markets with limited evidence and high stakeholder expectations.
Reserved for Decisive Consulting